# Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions

Study · id `cardio:ct-nct04434586` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04434586](<https://clinicaltrials.gov/study/NCT04434586>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04434586

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 166 participants.

## Technical summary

Registry record NCT04434586. Randomized; single masking; primary purpose treatment. Start 2020-06-16 (actual); primary completion 2026-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 166 participants (planned count; ClinicalTrials.gov record NCT04434586, source copy `cardio:ctgov-nct04434586-2025-12-23`, retrieved 2026-10-31)
- Started: 2020-06-16 (actual) (ClinicalTrials.gov record NCT04434586, source copy `cardio:ctgov-nct04434586-2025-12-23`, retrieved 2026-10-31)
- Primary completion: 2026-06 (anticipated) (ClinicalTrials.gov record NCT04434586, source copy `cardio:ctgov-nct04434586-2025-12-23`, retrieved 2026-10-31)
- Completion: 2026-06 (anticipated) (ClinicalTrials.gov record NCT04434586, source copy `cardio:ctgov-nct04434586-2025-12-23`, retrieved 2026-10-31)
- Countries: France (ClinicalTrials.gov record NCT04434586, source copy `cardio:ctgov-nct04434586-2025-12-23`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04434586-2025-12-23`, retrieved 2026-10-31)

## The registry's words

- Brief title: Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions
- Acronym: TOCAF
- Condition: Superficial Femoral Artery Stenosis
- Condition: Claudication
- Condition: Ischemic Leg
- Intervention (Device): femoropopliteal revascularization for TASC C or TASC D lesion
- Lead sponsor: University Hospital, Lille
- Lead sponsor class: OTHER
- Collaborator: Abbott
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: University Hospital, Lille (`cardio:org-university-hospital-lille`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)

## Provenance

Content hash: 21c3a191338597a35845a518b05dd71c7870f68578125b4babc28c8572affeab
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
